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INTRODUCTION
Clear cell sarcoma of the kidney (CCSK) is a rare pediatric 
primary renal tumor, but the second-most common primary 
renal malignancy in children after Wilms’ tumor. The annual 
Differentiation between Clear Cell Sarcoma of the Kidney 
and Wilms’ Tumor with CT
Choeum Kang1, Hyun Joo Shin1, Haesung Yoon1, Jung Woo Han2, Chuhl Joo Lyu2, Mi-Jung Lee1
1Department of Radiology and Research Institute of Radiological Science, Severance Children’s Hospital, Yonsei University College of Medicine, 
Seoul, Korea; 2Division of Pediatric Hematology and Oncology, Department of Pediatrics, Severance Hospital, Yonsei University College of 
Medicine, Seoul, Korea
Objective: Clear cell sarcoma of the kidney (CCSK) is the second-most common but extremely rare primary renal malignancy 
in children after Wilms’ tumor. The aims of this study were to evaluate the imaging features that could distinguish between 
CCSK and Wilms’ tumor and to assess the features with diagnostic value for identifying CCSK.
Materials and Methods: We reviewed the initial contrast-enhanced abdominal-pelvic CT scans of children with CCSK and 
Wilms’ tumor between 2010 to 2019. Fifty-eight children (32 males and 26 females; age, 0.3–10 years), 7 with CCSK, and 51 
with Wilms’ tumor, were included. The maximum tumor diameter, presence of engorged perinephric vessels, maximum density 
of the tumor (Tmax) of the enhancing solid portion, paraspinal muscle, contralateral renal vein density, and density ratios 
(Tmax/muscle and Tmax/vein) were analyzed on the renal parenchymal phase of contrast-enhanced CT. Fisher’s exact tests 
and Mann-Whitney U tests were conducted to analyze the categorical and continuous variables, respectively. Logistic 
regression and receiver operating characteristic curve analyses were also performed.
Results: The age, sex, and tumor diameter did not differ between the two groups. Engorged perinephric vessels were more 
common in patients in the CCSK group (71% [5/7] vs. 16% [8/51], p = 0.005). Tmax (median, 148.0 vs. 111.0 Hounsfield 
unit, p = 0.004), Tmax/muscle (median, 2.64 vs. 1.67, p = 0.002), and Tmax/vein (median, 0.94 vs. 0.59, p = 0.002) were 
higher in the CCSK compared to the Wilms’ group. Multiple logistic regression revealed that engorged vessels (odds ratio 
13.615; 95% confidence interval [CI], 1.770–104.730) and Tmax/muscle (odds ratio 5.881; 95% CI, 1.337–25.871) were 
significant predictors of CCSK. The cutoff values of Tmax/muscle (86% sensitivity, 77% specificity) and Tmax/vein (71% 
sensitivity, 86% specificity) for the diagnosis of CCSK were 1.97 and 0.76, respectively.
Conclusion: Perinephric vessel engorgement and greater tumor enhancement (Tmax/muscle > 1.97 or Tmax/vein > 0.76) 
are helpful for differentiating between CCSK and Wilms’ tumor in children aged below 10 years.
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incidence is 20 in the United States [1,2]. The male to 
female ratio of for the prevalence of CCSK was 2:1 and 
the mean age at diagnosis was 36 months [1,3,4]. The 
common clinical manifestations of CCSK include a palpable 
abdominal mass, abdominal pain, hematuria, and bone pain, 
similar to Wilms’ tumor [5,6]. However, the prognosis of 
CCSK is worse than that of Wilms’ tumor, although the use 
of high-intensity chemotherapy has dramatically improved 
the outcomes of CCSK [1,2,6,7]. Therefore, differentiating 
between CCSK and Wilms’ tumor is essential for treatment 
planning and predicting the prognosis.
The final diagnosis of CCSK requires histopathological 
confirmation. CCSK commonly appears as a heterogeneously 
enhancing mass without specific features on abdominal CT 
[5,8]. These tumors usually contain cystic, hemorrhagic, 
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or necrotic components. Calcifications within the tumor 
are observed infrequently. However, these imaging features 
of CCSK are non-specific and are similar to other primary 
renal tumors, especially Wilms’ tumors. To date, bone 
metastasis, which is observed only in advanced cases, is 
the only known finding that favors a diagnosis of CCSK over 
Wilms’ tumors [5,9]. Therefore, the differential diagnosis 
of CCSK is difficult with respect to other pediatric renal 
tumors. However, CCSK exhibits a distinctive vascular 
network histopathologically, which is not prominent in 
other pediatric renal tumors [10]. No study has analyzed 
the imaging findings that represent these pathological 
findings. Therefore, the aims of this study were to evaluate 
the imaging features that could distinguish between CCSK 
and Wilms’ tumor and to assess the features with diagnostic 
value for identifying CCSK. 
MATERIALS AND METHODS
Study Population
The Institutional Review Board of our hospital approved 
this retrospective study, and the need for informed consent 
was waived (IRB No. 1-2019-0090). The study population 
was retrospectively enrolled by conducting a medical chart 
review of children with renal tumors diagnosed before the 
age of 10 years. This study included 58 children with renal 
tumors for the comparison of the imaging features of CCSK 
and Wilms’ tumors: the CCSK group consisted of 7 patients 
(male:female = 2:5) and the Wilms’ tumor group consisted 
of 51 patients (male:female = 30:21). We reviewed the 
initial imaging studies in patients with Wilms’ tumor or 
CCSK and checked whether contrast-enhanced abdominal-
pelvic CT was performed or recorded at our hospital between 
January 2010 and December 2019. The demographic data 
assessed included sex, age at the time of the CT scan, and 
pathological findings including lymph node metastasis, 
presence of distant metastasis, and disease stage. Each 
patient’s follow-up duration and disease status (stable or 
progressed) at the last follow-up were also recorded. 
CT Scan and Image Review
We included all the registered CT examinations performed 
at and outside our hospital. Imaging was performed using 
various CT machines with different protocols due to the 
long study duration. Usually, axial and coronal images in 
the renal parenchymal enhancement phase, with a 3-mm 
thickness and contrast enhancement at 50–70 seconds 
delay after contrast injection were selected for the image 
review. We excluded CT scans without a renal parenchymal 
enhancement phase or images obtained after any treatment. 
Therefore, 7 patients from the Wilms’ tumor group and 1 
patient from the CCSK group were excluded due to lack of 
pre-treatment CT studies.
One pediatric radiologist with 15 years’ experience in 
this field performed a blind review of the initial CT images. 
Imaging findings such as maximal tumor diameter on axial 
or coronal imaging, presence of engorged perinephric 
vessels or tumor calcifications, internal heterogeneity of 
the tumor, venous tumor thrombus, and tumor rupture 
were evaluated (Fig. 1). Engorged perinephric vessels were 
defined as tortuous vascular dilatation around the kidneys 
with tumors. The tumor stage was determined on the basis 
of the presence of lymph node (short diameter > 1 cm) or 
liver metastasis on CT.
The mean tumor density (Tmean) and maximal tumor 
density (Tmax) of the most enhanced solid portion were 
measured. The mean density of the paraspinal muscles at 
the same level as that used for tumor density measurement 
and mean density of the renal vein of the contralateral 
kidney were also obtained. A single, circular region of 
interest was drawn on the most enhanced solid portion 
of each tumor on the axial imaging to obtain the tumor 
density values, and the necrotic or hemorrhagic portions, 
internal vessels, or calcifications were avoided (Fig. 
1). Other circular regions of interest were drawn at the 
paraspinal muscles and contralateral renal veins, and the 
adjacent soft tissues and beam-hardening artifacts from 
the vertebrae were avoided. The same pediatric radiologist 
repeated the measurement to evaluate its reliability, which 
was performed separately after an interval of more than 1 
month.
We calculated the density ratios by dividing Tmean 
by muscle density (Tmean/muscle) and dividing Tmax 
by muscle density (Tmax/muscle) to correct for the 
differences in the enhancement timing. We also calculated 
the density ratios by dividing Tmean by the contralateral 
renal vein density (Tmean/vein) and by dividing Tmax 
by the contralateral renal vein density (Tmax/vein) to 
eliminate the effect of several factors influencing tumor 
enhancement. 
Statistical Analysis
Statistical analyses were conducted using SPSS software 
version 23 (IBM Corp.) and MedCalc Statistical Software 
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version 19.3.1 (MedCalc Software Ltd.). The normality of 
distribution of the demographic data and imaging features 
was assessed using the Kolmogorov-Smirnov and Shapiro-
Wilk tests. Fisher’s exact test or Kendall’s tau-b test was 
used to determine the existence of a statistically significant 
difference between the categorical variables in the CCSK 
and Wilms’ tumor groups. The Mann-Whitney U test was 
used to compare the continuous variables between the 
two groups. Categorical data were expressed as counts 
and percentages, and continuous variables were expressed 
as the median and range. The intraclass correlation 
coefficient (ICC) was obtained to evaluate the reliability 
of the density measurement. Univariable and multivariable 
logistic regression analyses were performed to determine 
the diagnostic ability of the significant features for CCSK. 
The diagnostic performances of the imaging features for 
identifying CCSK were assessed using receiver operating 
characteristic (ROC) curve analysis and compared using the 
area under the curve (AUC). P values less than 0.05 were 
considered statistically significant for all statistical tests.
RESULTS
Demographics and Clinical Features
Thirty patients underwent initial CT imaging outside 
our hospital. Needle biopsy was used for the pathological 
confirmation of the tumor in 5 patients from the Wilms’ 
tumor group due to inoperability at the time of diagnosis 
(bilateral lesions in 2 patients, tumor rupture in 2 patients, 
and malignant thrombus extension to the inferior vena cava 
in one patient). Nephrectomy was used for pathological 
confirmation in all the other patients. Immunohistochemical 
staining showed that CCSK demonstrated positive INI-1 
expression, to exclude rhabdoid tumor and was negative 
for WT-1, which could exclude Wilms’ tumor. The presence 
of specific curvilinear or arborizing vascular patterns were 
confirmed using CD34 staining in the CCSK group. The 
clinical features of both groups are shown in Table 1. The 
median age at the time of initial CT examination was 2 
years (range, 1–8 years) in the CCSK group and 2 years 
(range, 0.3–10 years) in the Wilms’ tumor group, which was 
not significantly different (p = 0.691). 
The CCSK group consisted of 4 patients with stage 1, 1 
patient with stage 2, and 2 patients with stage 4 disease; 
while the Wilms’ tumor group consisted of 28 patients with 
stage 1, 7 patients with stage 2, 4 patients with stage 
3, 8 patients with stage 4 disease, and 4 patients with 
bilateral tumors. Lymph node metastasis was confirmed 
pathologically in 3 patients (43%) in the CCSK group and 6 
patients (12%) in the Wilms’ tumor group. The tumor stage 
Fig. 1. A 3-year-old girl with a left renal mass confirmed as clear cell sarcoma of the kidney.
A-C. The axial (A, B) and coronal (C) contrast-enhanced abdominal-pelvic CT images in the renal parenchymal phase demonstrate a large, 
heterogeneously enhancing mass (star) replacing the left kidney tissue with engorged perinephric vessels (arrows) under the left renal tumor. 
Regions of interest (circles) marked on an axial (A) image were used to obtain the mean (Tmean) and maximum (Tmax) tumor densities of the 
most enhancing solid portion and mean density of the paraspinal muscle. The Tmean was 212.7 HU, Tmax was 277.0 HU, paraspinal muscle 
density was 80.0 HU, and contralateral renal vein density was 264.7 HU. Both Tmax/muscle (3.46 > 1.97) and Tmax/vein (1.05 > 0.76) were 
higher than the suggested cutoff values. HU = Hounsfield unit, Tmax = maximum density of the tumor, Tmax/muscle = Tmax divided by paraspinal 





did not differ significantly between the two groups (p = 
0.791). Distant metastases were observed in 2 patients 
(29%) with lung or bone metastases in the CCSK group 
and in 8 patients (16%) with lung and/or liver metastases 
in the Wilms’ tumor group. The prevalence of pathologic 
lymph node metastasis and distant metastasis did not differ 
between the two groups (Table 1).
The follow-up interval ranged from 67–2803 days with 
a median of 1237 days in the CCSK group and 15–3360 
days with a median of 994 days in the Wilms’ tumor group. 
Disease progression was observed in 1 patient (14%, 1/7) 
in the CCSK group and 8 patients (16%, 8/51) in the Wilms’ 
tumor group during the follow-up period (p = 0.704).
Comparison of Imaging Features between the CCSK and 
Wilms’ Tumor Groups
The maximum tumor diameter was 8–15 cm with a median 
value of 11 cm in the CCSK group and 3–24 cm with a 
median value of 10 cm in the Wilms’ tumor group, which 
was not significantly different (p = 0.640). 
More than 70% of patients (71%, 5/7) in the CCSK 
group had perinephric vessel engorgement, compared with 
less than 20% (16%, 8/51) patients in the Wilms’ tumor 
group. Engorged perinephric vessels were significantly more 
frequent in the CCSK group compared to the Wilms’ tumor 
group (p = 0.005) (Figs. 1, 2). The age (p = 0.354) or tumor 
stage (p = 0.608) of patients with and without perinephric 
engorged vessels did not differ significantly. However, 
tumor size was larger in patients with engorged perinephric 
vessels (median, 12 cm [9–24 cm] vs. 10 cm [3–15 cm],  
p = 0.038) only in the Wilms’ tumor group. 
Intratumoral calcification was not observed in the CCSK 
group but was observed in 4 patients in the Wilms’ tumor 
group. Almost all tumors in both groups, except one case 
of Wilms’ tumor, showed a heterogeneous enhancement 
pattern. Venous tumor thrombus extension was observed 
in only 2 patients in the Wilms’ tumor group, of which 
1 patient also had engorged perinephric vessels. Tumor 
rupture was only seen in 5 cases in the Wilms’ tumor group. 
The ICCs for reliability of the density measurement were 
0.963 (95% confidence interval [CI], 0.937–0.978) for 
Tmean, 0.949 (95% CI, 0.914–0.970) for Tmax, 0.840 
(95% CI, 0.729–0.905) for paraspinal muscle density, and 
0.943 (95% CI, 0.903–0.966) for contralateral renal vein 
density (all, p < 0.001). Only the first measurement data 
were used in the density study, based on these good-to-
excellent reliability results. Among the measured density 
values, both Tmean and Tmax were significantly higher 
Table 1. Comparison of Clinical and Imaging Features between the CCSK and Wilms’ Tumor Groups
CCSK Group (n = 7) Wilms’ Tumor Group (n = 51) P
Clinical features
Age, years 2 (1–8) 2 (0.3–10) 0.691
Sex, male:female 2:5 30:21 0.135
Lymph node metastasis 3 (43%) 6 (12%) 0.067
Distant metastasis* 2 (29%) 8 (16%) 0.347
Disease progression during follow-up 1 (14%) 8 (16%) 0.704
Imaging features
Maximum tumor diameter, cm 11 (8–15) 10 (3–24) 0.640
Perinephric engorged vessels 5 (71%) 8 (16%) 0.005
Calcification of tumor 0 4 (8%) 0.589
Tmean, HU 98.1 (69.5–212.7) 70.9 (45.2–192.4) 0.012
Tmax, HU 148 (109–277) 111 (69–251) 0.004
Muscle density, HU 64.9 (55.1–82.6) 64.5 (43.7–89.6) 0.591
Tmean/muscle 1.53 (1.26–2.66) 1.09 (0.77–3.02) 0.002
Tmax/muscle 2.64 (1.70–3.46) 1.67 (1.08–3.69) 0.002
Contralateral renal vein density, HU 192.7 (112.2–264.7) 189.2 (93.7–376.1) 0.944
Tmean/vein 0.53 (0.41–0.83) 0.39 (0.20–0.71) 0.008
Tmax/vein 0.94 (0.58–1.05) 0.59 (0.29–0.87) 0.002
Data are median (range) or number (percentage), if not otherwise specified. P values from Fisher’s exact test for categorical variables and 
Mann-Whitney U test for continuous variables. *Metastasis sites were lung or bone in the CCSK group and lung and/or liver in the Wilms’ 
tumor group. CCSK = clear cell sarcoma of the kidney, HU = Hounsfield unit, Tmax = maximum density of the tumor, Tmax/muscle = Tmax 
divided by paraspinal muscle density, Tmax/vein = Tmax divided by contralateral renal vein density, Tmean = mean density of the tumor, 
Tmean/muscle = Tmean divided by paraspinal muscle density, Tmean/vein = Tmean divided by contralateral renal vein density
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in the CCSK group than those in the Wilms’ tumor group 
(median, 98.1 vs. 70.9 Hounsfield unit [HU] for Tmean 
and 148.0 vs. 111.0 HU for Tmax; p = 0.012 and 0.004 for 
each) (Table 1). However, the paraspinal muscle density and 
contralateral renal vein density did not differ significantly. 
Both the Tmean/muscle (median, 1.53 vs. 1.09; p = 0.002) 
and Tmax/muscle (median, 2.64 vs. 1.67; p = 0.002) ratios 
were also significantly higher in the CCSK group than those 
in the Wilms’ tumor group (Fig. 3). The Tmean/vein (median, 
0.53 vs. 0.39; p = 0.008) and Tmax/vein (median, 0.94 vs. 
0.59; p = 0.002) (Table 1) ratios were also higher in the 
CCSK group than those in the Wilms’ tumor group.
Assessment of Diagnostic Performances for CCSK 
Diagnosis
Univariable logistic regression analyses were performed 
using the imaging features that differed significantly 
between the two groups, i.e., perinephric vessel 
Fig. 2. Patients with clear cell sarcoma of the kidney.
A-G. The representative CT images demonstrate heterogeneously enhancing renal masses without (A, B) and with (C-G) engorged perinephric 
vessels (arrows) in patients with clear cell sarcoma of the kidney. (A) An 8-year-old boy, (B) a 1-year-old boy, (C) a 3-year-old girl (same 







engorgement and density variables. Perinephric vessel 
engorgement, Tmean, Tmax, Tmean/muscle, Tmax/muscle, 
Tmean/vein, and Tmax/vein were significant parameters 
(Table 2). Multivariable analyses also demonstrated the 
significance of perinephric vessel engorgement (odds ratio, 
13.615 [95% CI, 1.770–104.730], p = 0.012) and Tmax/
muscle (odds ratio 5.881 [95% CI, 1.337–25.871], p = 
0.019). Tmean, Tmax, Tmean/muscle, Tmean/vein, and 
Tmax/vein were not included in the multivariable analysis 
due to the possible confounding effect of Tmax/muscle. 
The AUC values (95% CI) used to evaluate the diagnostic 
performance of these features were 0.822 (0.699–0.910) 
Fig. 3. A 3-year-old boy with a left renal mass confirmed as Wilms’ tumor.
A, B. The axial (A) and coronal (B) contrast-enhanced abdominal-pelvic CT images in the renal parenchymal phase demonstrate a large, 
heterogeneous mass (star) replacing the left kidney tissue without perinephric vessel engorgement, showing less enhancement than the renal 
parenchyma. Regions of interest (circles) were marked on the axial image to obtain the mean (Tmean) and maximum (Tmax) tumor densities of 
the most enhancing solid portion and mean density of the paraspinal muscle. The Tmean was 47.5 HU, Tmax was 95.0 HU, paraspinal muscle 
density was 61.2 HU, and contralateral renal vein density was 145.6 HU. Both Tmax/muscle (1.55 < 1.97) and Tmax/vein (0.65 < 0.76) were 
lower than the suggested cutoff values. HU = Hounsfield unit, Tmax = maximum density of the tumor, Tmax/muscle = Tmax divided by paraspinal 
muscle density, Tmax/vein = Tmax divided by contralateral renal vein density, Tmean = mean density of the tumor
A B
Table 2. Univariable and Multivariable Logistic Regression Analyses for the Diagnosis of CCSK
Variables
Univariable Analysis Multivariable Analysis
OR 95% CI P OR 95% CI P OR 95% CI P
Engorged vessels 13.438 2.210–81.714 0.005 13.615 1.770–104.730 0.012 4.018 0.456–35.412 0.019
Tmean, HU 1.022 1.004–1.040 0.019
Tmax, HU 1.023 1.006–1.040 0.009
Tmean/muscle 4.557 1.181–17.585 0.028
Tmax/muscle 5.723 1.540–21.263 0.009 5.881 1.337–25.871 0.019
Tmean/vein, x 10* 2.603 1.389–4.877 0.003
Tmax/vein, x 10* 3.116 1.488–6.523 0.003 2.588 1.171–5.723 0.002
*10 multiplied values were evaluation for these variables. CCSK = clear cell sarcoma of the kidney, CI = confidence interval, HU = 
Hounsfield unit, OR = odds ratio, Tmax = maximum density of the tumor, Tmax/muscle = Tmax divided by paraspinal muscle density, 
Tmax/vein = Tmax divided by contralateral renal vein density, Tmean = mean density of the tumor, Tmean/muscle = Tmean divided by 
paraspinal muscle density, Tmean/vein = Tmean divided by contralateral renal vein density
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for Tmax and 0.845 (0.725–0.926) for Tmax/muscle, which 
were not significantly different (p = 0.657). A cutoff value 
of 1.97 for Tmax/muscle showed 86% sensitivity and 77% 
specificity for the diagnosis of CCSK (p < 0.001) (Fig. 4). 
The cutoff value of Tmax was 134 HU with 71% sensitivity 
and 84% specificity. The results of the other density 
parameters are presented in Table 3. The AUC values of 
these parameters were not different. 
The AUC value (95% CI) for the combination of Tmax/
muscle and perinephric vessel engorgement was 0.887 
(0.776–0.955) (p < 0.001), which was slightly higher than 
that for Tmax/muscle, without any significant difference in 
the pairwise comparisons of the two ROC curves (p = 0.524).
DISCUSSION
CCSK is an aggressive malignant renal tumor that requires 
chemotherapy with doxorubicin, which is associated with 
the risks of cardiotoxicity, nephrotoxicity, and reduced 
fertility. Therefore, the differential diagnosis of CCSK from 
Wilms’ tumor is an essential task. In this study, various 
clinical and CT imaging features of CCSK were compared 
with those of Wilms’ tumor using a retrospective review. No 
significant differences were observed between the clinical 
features of the two groups. However, imaging features such 
as perinephric vessel engorgement and higher tumor density 
values were features that distinguished CCSK from Wilms’ 
tumor. A Tmax/muscle cutoff value of 1.97 showed 86% 
sensitivity and 77% specificity for the diagnosis of CCSK. 
Therefore, we determined that these findings were helpful 
in differentiating CCSK from Wilms’ tumors. 
Wilms’ tumor usually appears as a large, heterogeneous 
intrarenal mass on abdominal CT. These tumors demonstrate 
a lower degree of enhancement compared to the adjacent 
normal renal parenchyma [5]. Necrosis and hemorrhage 
are commonly observed in the intratumoral portion, and 
calcifications are seen in approximately 15% of Wilms’ 
tumors [11,12]. However, these features may also be 
observed in CCSK [8]. CCSK also usually appears as a 
heterogeneously enhancing solid renal mass with cysts on 
abdominal CT. Currently, bone metastasis is the only known 
indicator of CCSK that distinguishes it from Wilms’ tumor 
[9]. None of the known imaging features can distinguish 
between CCSK and Wilms’ tumor in patients without bone 
metastasis [5,13]. 
Table 3. Diagnostic Performance of Density Parameters for the Diagnosis of CCSK 
Variables AUC 95% Confidence Interval P Cutoff Value Sensitivity (%) Specificity (%)
Tmean, HU 0.790 0.663–0.886 < 0.001 > 84 85.7 74.5
Tmax, HU 0.822 0.699–0.910 < 0.001 > 134 71.4 84.3
Tmean/muscle 0.840 0.721–0.923 < 0.001 > 1.25 100 64.7
Tmax/muscle 0.845 0.725–0.926 < 0.001 > 1.97 85.7 76.5
Tmean/vein 0.804 0.679–0.897 < 0.001 > 0.4 100 54.9
Tmax/vein 0.847 0.729–0.928 < 0.001 > 0.76 71.4 86.3
AUC = area under the curve, CCSK = clear cell sarcoma of the kidney, HU = Hounsfield unit, Tmax = maximum density of the tumor, Tmax/
muscle = Tmax divided by paraspinal muscle density, Tmax/vein = Tmax divided by contralateral renal vein density, Tmean = mean density 


















Fig. 4. Receiver operating characteristic curves for the 
diagnosis of clear cell sarcoma of the kidney. Two analyses were 
performed using a single variable, i.e., Tmax/muscle and combined 
variables, i.e., Tmax/muscle and perinephric vessel engorgement. 
The values of the area under the curve (95% confidence interval) 
were 0.845 (0.725–0.926; p < 0.001) for the single variable and 
0.887 (0.776–0.955; p < 0.001) for the combined variables, without 





CCSK often presents as a large, well-circumscribed, 
sharply demarcated mass on gross pathological examination 
[7]. These tumors arise from the medullary region of 
the kidney and replace normal renal tissue [14]. The 
microscopic features include nests or cords of small, plump 
cells separated by networks of delicate fibrovascular 
septa. The blood vessels in the fibrovascular septa contain 
regular branching capillaries, which exhibit a chicken-
wire pattern, which is typical of CCSK [1,15]. Although 
CCSK is a histologically diverse tumor with myxoid (50%), 
sclerosing (35%), cellular (26%), epithelioid (13%), 
spindle (7%), storiform (4%), and anaplastic (2.6%) 
patterns [1], the distinctive complex vascular network can 
be a helpful diagnostic finding. Our study hypothesized 
that the distinctive vasculature of CCSK may manifest as 
distinct imaging findings on CT, which could differentiate 
it from Wilms’ tumor. We found a higher frequency of 
peritumoral vessel engorgement and higher degree of tumor 
enhancement in CCSK.
Other hypervascular renal tumors can present with 
hyperenhancement on CT and peritumoral neovascularity. 
One study reported that sarcomatoid renal cell carcinomas 
demonstrated larger tumor size and larger peritumoral 
vessels compared to clear cell carcinomas in adults [16]. 
Although rare in childhood, renal cell carcinoma may occur 
in patients aged 15 to 19 years. Renal clear cell carcinoma 
[17], alveolar soft part sarcoma arising from the kidney [18], 
and solitary fibrous tumor from the retroperitoneum [19] 
can also present with prominent feeding vessels. However, 
no reports were found on peritumoral vascular engorgement 
associated with CCSK in children. To the best of our 
knowledge, this is the first study to identify more frequent 
peritumoral vascular engorgement and greater internal 
enhancement of the solid portion of the CCSK compared to 
Wilms’ tumor in children. Although we could not directly 
compare the imaging findings with the pathologic results, 
our tumor density evaluation demonstrated good-to-
excellent reliability and showed consistent results when 
normalized with paraspinal muscle density and contralateral 
renal vein density. Perinephric vessel engorgement was not 
associated with the patient’s age, tumor size, or disease 
stage in the CCSK group, even though larger tumor size 
was associated with perinephric vessel engorgement in 
the Wilms’ tumor group. Additional studies are needed to 
correlate imaging and pathological findings. 
Our study had several limitations. First, the study 
population was small, owing to the rarity of CCSK in 
children. Thus, the study included only 7 patients with 
CCSK, despite the 10-year study period. Second, our study 
included CT scans that were obtained outside our hospital 
using different protocols. All the included CT scans were 
in renal parenchymal phase, but the timing or amount of 
contrast agents used could have been different. We used 
the enhancement ratio to correct for the variations in 
the enhancement timing, which demonstrated significant 
differences between CCSK and Wilms’ tumors. However, 
further studies with optimal enhancement timing are 
needed. Third, we could not directly compare the imaging 
findings and results of the pathological examination 
in this retrospective study. We hypothesized that the 
imaging findings could be different because of the greater 
hypervascular character of CCSK compared to Wilms’ tumor. 
However, CCSK has several subtypes, and Wilms’ tumors 
can also be hypervascular, as evidenced by the peritumoral 
vessel engorgement observed in some patients in this study. 
Further prospective studies with direct comparison of the 
imaging and pathological findings are needed.
In conclusion, imaging features such as perinephric vessel 
engorgement and higher tumor enhancement (Tmax/muscle 
> 1.97) were helpful in differentiating CCSK from Wilms, 
tumor in children with primary renal tumors under 10 years 
of age.
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